Robertson named associate director of translational research

January 15, 2009

Penn State Hershey Cancer Institute, Penn State Milton S. Hershey Medical Center has appointed Gavin P. Robertson, associate professor, pharmacology, pathology and dermatology, to associate director, translational research. In this new role, Robertson will continue his work of fostering translational studies in the Cancer Institute.

“My duties are to bridge the gaps in novel cancer drug development that exist between basic research and clinical areas within the Institute, thus making better cancer therapies available to patients,” said Robertson. “More specifically, I will be in charge of formulating the overall direction and development of the Cancer Institute drug portfolio, developing and overseeing internal and external corporate interactions that are necessary to enable novel experimental cancer drugs to be tested in our clinics, managing interaction with the Food and Drug Administration regarding drugs for which Investigational New Drug status is being sought, and interacting with potential donors to facilitate funding for development of novel drugs to better treat particular cancers.” Robertson also manages a translational research program for malignant melanoma.

Dr. Thomas P. Loughran, director, said, “Dr. Robertson is an ideal choice for this position as he has played a critical role in the development of the Experimental Therapeutics program with its focus on drug discovery and delivery.”

(Media Contacts)

Last Updated March 19, 2009